tailieunhanh - Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer

The human EGFR2 (HER2) signaling pathway is one of the most actively studied targets in cancer transformation research. Triplex-forming oligonucleotides (TFOs) activate DNA damage and induce apoptosis. We aim to encapsulate TFO-HER2 with nano-particle ZW-128 to suppress breast cell growth in vitro and in vivo. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN